Genetic ablation of GSDMD markedly attenuates excessive inflammatory responses and pulmonary dysfunction, underscoring the pivotal role of pyroptosis and inflammatory activation in BPD progression and establishing a foundation for future targeted therapeutic investigations. The gene discussed is GSDMD; the disease is bronchopulmonary dysplasia.